Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase-negative cells
已知能靶向拓扑异构酶II的特定椭圆吡啶衍生物,可抑制端粒酶阴性细胞中的端粒替代延长(ALT)途径。
期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-020-03213-x
Zencir, Sevil; Hsieh, Meng-Hsun; Hsu, Joel-Sean; Ergun, Yavuz; Chou, Guan-Ling; Li, Tsai-Kun; Teng, Shu-Chun; Topcu, Zeki